Suchergebnisse - "Polyak, Kornelia"

PubPharm (349)

1

Principles governing A-to-I RNA editing in the breast cancer transcriptome

enthalten in: bioRxiv.org | 2024

von Fumagalli, D. | Gacquer, D. | Rothé, F. | +16

2

Author Correction : Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments

enthalten in: Nature cell biology | 2024

von Janiszewska, M. | Tabassum, D. | Castaño, Z. | +21

ErratumFor: Nat Cell Biol. 2019 Jul;21(7):879-888. - PMID 31263265

3

HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial

enthalten in: The Journal of clinical investigation | 2024

von Li, Z. | Metzger Filho, O. | Viale, G. | +18

4

TBCRC 039 : a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer

enthalten in: Breast cancer research : BCR | 2024

von Lynce, F. | Stevens, L. | Li, Z. | +26

5

Heterogeneity and transcriptional drivers of triple-negative breast cancer

enthalten in: Cell reports | 2023

von Jovanović, B. | Temko, D. | Stevens, L. | +35

6

Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2023

von Nishida, J. | Cristea, S. | Bodapati, S. | +16

7

Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer

enthalten in: Molecular cancer therapeutics | 2023

von Alečković, M. | Li, Z. | Zhou, N. | +14

8

HATS off to KAT6A/B inhibitors : A new way to target estrogen-receptor-positive breast cancer

enthalten in: Cell chemical biology | 2023

von Jeselsohn, R. | Polyak, K.

CommentOn: Cell Chem Biol. 2023 Oct 19;30(10):1191-1210.e20. - PMID 37557181

9

Clinical and translational relevance of intratumor heterogeneity

enthalten in: Trends in cancer | 2023

von Goyette, M. | Lipsyc-Sharf, M. | Polyak, K.

10

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ : Analysis of TBCRC 038 and RAHBT cohorts

enthalten in: Cancer cell | 2023

von Strand, S. | Rivero-Gutiérrez, B. | Houlahan, K. | +49

ErratumFor: Cancer Cell. 2022 Dec 12;40(12):1521-1536.e7. - PMID 36400020

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]